<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Infect Dis</journal-id>
      <journal-title>BMC Infectious Diseases</journal-title>
      <issn pub-type="epub">1471-2334</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">16307688</article-id>
      <article-id pub-id-type="pmc">1314895</article-id>
      <article-id pub-id-type="publisher-id">1471-2334-5-107</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2334-5-107</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Catheter-associated bacteremia by Mycobacterium senegalense in Korea</article-title>
      </title-group>
      <contrib-group>
        <contrib id="A1" equal-contrib="yes" contrib-type="author">
          <name>
            <surname>Oh</surname>
            <given-names>Won Sup</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>wsoh@smc.samsung.co.kr</email>
        </contrib>
        <contrib id="A2" equal-contrib="yes" contrib-type="author">
          <name>
            <surname>Ko</surname>
            <given-names>Kwan Soo</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>ksko@ansorp.org</email>
        </contrib>
        <contrib id="A3" corresp="yes" contrib-type="author">
          <name>
            <surname>Song</surname>
            <given-names>Jae-Hoon</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>jhsong@ansorp.org</email>
        </contrib>
        <contrib id="A4" contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Mi Young</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>mylee@ansorp.org</email>
        </contrib>
        <contrib id="A5" contrib-type="author">
          <name>
            <surname>Ryu</surname>
            <given-names>Seong Yeol</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>seongyeol.ryu@samsung.com</email>
        </contrib>
        <contrib id="A6" contrib-type="author">
          <name>
            <surname>Heo</surname>
            <given-names>Sangtaek</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>sangtaek.heo@samsung.com</email>
        </contrib>
        <contrib id="A7" contrib-type="author">
          <name>
            <surname>Kwon</surname>
            <given-names>Ki Tae</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>kt.kwon@samsung.com</email>
        </contrib>
        <contrib id="A8" contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Jang-Ho</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>jh56.lee@samsung.com</email>
        </contrib>
        <contrib id="A9" contrib-type="author">
          <name>
            <surname>Peck</surname>
            <given-names>Kyong Ran</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>krpeck@smc.samsung.co.kr</email>
        </contrib>
        <contrib id="A10" contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Nam Yong</given-names>
          </name>
          <email>micro.lee@samsung.com</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Division of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea</aff>
      <aff id="I2"><label>2</label>Department of Laboratory Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea</aff>
      <aff id="I3"><label>3</label>Asian-Pacific Research Foundation for Infectious Diseases (ARFID), Seoul, Korea</aff>
      <pub-date pub-type="collection">
        <year>2005</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>25</day>
        <month>11</month>
        <year>2005</year>
      </pub-date>
      <volume>5</volume>
      <fpage>107</fpage>
      <lpage>107</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2334/5/107"/>
      <history>
        <date date-type="received">
          <day>17</day>
          <month>8</month>
          <year>2005</year>
        </date>
        <date date-type="accepted">
          <day>25</day>
          <month>11</month>
          <year>2005</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2005 Oh et al; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2005</copyright-year>
        <copyright-holder>Oh et al; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
          <!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author>
               Oh
               Sup
               Won
               
               wsoh@smc.samsung.co.kr
            </dc:author><dc:title>
            Catheter-associated bacteremia by Mycobacterium senegalense in Korea
         </dc:title><dc:date>2005</dc:date><dcterms:bibliographicCitation>BMC Infectious Diseases 5(1): 107-. (2005)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-2334(2005)5:1&#x0003c;107&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-2334</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>-->
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Background</title>
          <p>Rapidly growing mycobacteria is recognized as one of the causative agents of catheter-related infections, especially in immunocompromised hosts. To date, however, <italic>Mycobacterium senegalense</italic>, which was known as the principal pathogen of bovine farcy, has not been reported in human infection.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>We describe the first case of human infection by <italic>M. senegalense</italic>, which has caused catheter-related bloodstream infection in a cancer patient in Korea. The microorganism was identified by the 16S rRNA gene, <italic>rpoB</italic>, and 16S-23S rRNA gene internal transcribed spacer (ITS) sequence analyses.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>Our first report of catheter-associated bacteremia caused by <italic>M. senegalense </italic>suggests the zoonotic nature of this species and indicates the expansion of mycobacterial species relating to human infection. <italic>M. senegalense </italic>should be considered as one of the causes of human infections in the clinical practice.</p>
        </sec>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p><italic>Mycobacterium senegalense </italic>was originally described by Chamoiseau in 1973 as a subspecies of <italic>Mycobacterium farcinogenes </italic>[<xref ref-type="bibr" rid="B1">1</xref>]. However, it was later recognized as a distinct species closely related to <italic>M. fortuitum </italic>[<xref ref-type="bibr" rid="B2">2</xref>]. <italic>M. senegalense </italic>is known as the principal pathogen of bovine farcy, which is a chronic disease of skin and superficial lymphatics of cattle in East and Central Africa [<xref ref-type="bibr" rid="B3">3</xref>]. Unlike other rapidly growing mycobacteria, human infection by <italic>M. senegalense </italic>has not been reported to date. Here we report the first case of central venous catheter (CVC) infection caused by <italic>M. senegalense</italic>.</p>
    </sec>
    <sec>
      <title>Case presentation</title>
      <p>A 49-year-old woman with non-Hodgkin's lymphoma was admitted to the hospital because of fever for several hours. The patient had been treated for lymphoma since 3 months ago. Five days before admission, the patient was treated with the third cycle of CHOP plus rituximab (R-CHOP). She had no history of travel or contact with animals including cows or their products. Physical examination revealed high fever of 39.8&#xB0;C. The patient had a subclavian cuffed-CVC(Hickman catheter) on the right side with no evidence of the inflammation at the exit site. Laboratory data and chest radiograph were within normal limits. Three sets of blood samples for cultures were drawn through CVC lines (2 sets) and a peripheral vein (1 set), respectively. The patient was treated empirically with vancomycin (1 g every 12 h intravenously). On the second hospital day, all 3 sets of blood cultures grew gram-positive, acid-fast bacilli. The cultures from the CVC became positive more than 2 hours earlier than that from a peripheral vein. Non-pigmented and pinpoint-shaped colonies were observed on blood or chocolate agar plate after 3 days of incubation at 37&#xB0;C. It did not grow well on McConkey agar plate. As it grows, the color of the colonies becomes pale-yellow. Vancomycin was replaced by imipenem/cilastatin (500 mg every 6 h intravenously) and amikacin (375 mg every 12 h intravenously). On the sixth hospital day, the CVC was removed because of persistent fever. After removal of CVC, the patient became afebrile and the repeated blood cultures became negative. In vitro susceptibility test was performed by broth microdilution test as described by the National Committee for Clinical Laboratory Standards (NCCLS) guidelines [<xref ref-type="bibr" rid="B4">4</xref>]. The result of in vitro susceptibility test was shown in Table <xref ref-type="table" rid="T1">1</xref>. The isolates were susceptible to most antimicrobial agents tested except vancomycin. The patient was further treated with oral ciprofloxacin (500 mg every 12 hours) and doxycycline (100 mg every 12 hours) for 4 weeks. She had been doing well with no evidence of recurrence for the next 3 months.</p>
      <table-wrap position="float" id="T1">
        <label>Table 1</label>
        <caption>
          <p>Antibiotic susceptibility testing using broth microdilution for strain SMC-7485.</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <td align="center">Antibiotic agents</td>
              <td align="center">MIC (&#x3BC;g/mL)</td>
              <td align="center">Susceptibility <sup>a</sup></td>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left">Amikacin</td>
              <td align="center">0.5</td>
              <td align="center">S</td>
            </tr>
            <tr>
              <td align="left">Cefoxitin</td>
              <td align="center">8</td>
              <td align="center">S</td>
            </tr>
            <tr>
              <td align="left">Ciprofloxacin</td>
              <td align="center">0.25</td>
              <td align="center">S</td>
            </tr>
            <tr>
              <td align="left">Clarithromycin</td>
              <td align="center">0.25</td>
              <td align="center">S</td>
            </tr>
            <tr>
              <td align="left">Doxycycline</td>
              <td align="center">0.12</td>
              <td align="center">S</td>
            </tr>
            <tr>
              <td align="left">Imipenem</td>
              <td align="center">4</td>
              <td align="center">S</td>
            </tr>
            <tr>
              <td align="left">Tobramycin</td>
              <td align="center">4</td>
              <td align="center">S</td>
            </tr>
            <tr>
              <td align="left">Amoxicillin-clavulanic acid</td>
              <td align="center">16/8</td>
              <td align="center">-</td>
            </tr>
            <tr>
              <td align="left">Moxifloxacin</td>
              <td align="center">0.12</td>
              <td align="center">S</td>
            </tr>
            <tr>
              <td align="left">Trimethoprim-sulfamethoxazole</td>
              <td align="center">4/76</td>
              <td align="center">-</td>
            </tr>
            <tr>
              <td align="left">Vancomycin</td>
              <td align="center">16</td>
              <td align="center">I</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <p><sup>a</sup>S, susceptible; I, intermediate. MIC interpretative breakpoints of amoxicillin-clavulanic acid, moxifloxacin, trimethoprim-sulfamethoxazole, and vancomycin are not shown by NCCLS [4] for rapidly growing mycobacteria. Those of moxifloxacin and vancomycin are those recommended for aerobic organisms.</p>
        </table-wrap-foot>
      </table-wrap>
    </sec>
    <sec>
      <title>Molecular identification</title>
      <p>Conventional automated methods in the clinical microbiology laboratory such as VITEK 2 system (bioM&#xE9;rieux, Hazelwood, Mo.) failed to identify this isolate to a given species. Thus, this isolate ("SMC-7485"), was subjected to the 16S rRNA gene, <italic>rpoB</italic>, and 16S-23S rRNA gene internal transcribe spacer (ITS) sequence analyses for bacterial identification. Genomic DNA was extracted by using the G-Spin Genomic DNA Extraction Kit (iNtRON, Seoul, Korea). DNA amplification of 16S rRNA gene, <italic>rpoB</italic>, and ITS were performed by using primer sets 16S-F3 (5'-CAG GCC TAA CAC ATG CAA GT-3')/16S-R3 (5'-GGG CGG WGT GTA CAA GGC-3'), MF (5'-CGA CCA CTT CGG CAA CCG-3')/MR (5'-TCG ATC GGG CAC ATC CGG-3'), and ITS-F (TTG TAC ACA CCG CCC GTC A-3')/ITS-R (5'-TCT CGA TGC CCG GCA TCC ACC-3') [<xref ref-type="bibr" rid="B5">5</xref>-<xref ref-type="bibr" rid="B7">7</xref>], respectively. Template DNA (ca. 50 ng) and 20 pmol of each primer were added to a PCR mixture tube (AccuPower PCR PreMix; Bioneer, Daejeon, Korea) containing 1 unit of T<italic>aq </italic>DNA polymerase, each deoxynucleoside triphosphate at a concentration of 250 &#x3BC;M, 10 mM Tric-HCl (pH 8.3), 10 mM KCl, 1.5 mM MgCl<sub>2</sub>, and gel loading dye [<xref ref-type="bibr" rid="B8">8</xref>]. The reaction mixture was then subjected to 35 cycles for amplification. Each cycle consisted of 30 sec at 95&#xB0;C for denaturation, 30 sec at 60&#xB0;C, and 1 min at 72&#xB0;C for extension, followed by final extension at 72&#xB0;C for 5 min. Amplified PCR product was purified for sequencing using PCR purification kit (CoreOne, Seoul, Korea). The purified PCR product was sequenced directly using the same primers of PCR amplification at both directions. Sequence editing and analyses were performed with the EditSeq and MegAlign programs in DNASTAR (Windows version 3.12e; Madison, Wis.). Determined sequence was compared with public database, GenBank, with the BLASTn program <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/blast"/>, and sequences showing high similarity were retrieved for further analysis.</p>
      <p>16S rRNA gene sequence (1,393 bp) of the strain SMC-7485 showed 100% similarities with those of <italic>Mycobacterium senegalense </italic>ATCC 35796 [GenBank: <ext-link ext-link-type="gen" xlink:href="AF480596">AF480596</ext-link>] and <italic>Mycobacterium farcinogenes </italic>ATCC 35753 [GenBank: <ext-link ext-link-type="gen" xlink:href="AF055333">AF055333</ext-link>]. It also showed very high similarities (99.5% &#x2013; 99.7%) with those of <italic>Mycobacterium porcinum, Mycobacterium housetonense, Mycobacterium neworleansense, Mycobacterium boenickei, Mycobacterium septicum</italic>, and <italic>Mycobacterium fortuitum</italic>. 16S rRNA gene sequence analysis suggested that the strain SMC-7485 belong to <italic>M. senegalense </italic>or <italic>M. farcinogenes </italic>of <italic>M. fortuitum </italic>group. However, more decisive identification could not be available due to no divergence of 16S rRNA gene sequence between two species [<xref ref-type="bibr" rid="B9">9</xref>].</p>
      <p>To clarify identification of the strain SMC-7485, we analyzed <italic>rpoB </italic>and ITS sequences. <italic>rpoB </italic>gene sequence (301 bp) of SMC-7485 showed that it was the closest to <italic>M. senegalense </italic>ATCC 35796 [GenBank: <ext-link ext-link-type="gen" xlink:href="AF057483">AF057483</ext-link>], i.e. 99.7% similarity. The species showing the next highest similarities were <italic>M. porcinum, Mycobacterium wolinskyi, Mycobacterium goodii</italic>, and <italic>M. septicum </italic>(96.9% &#x2013; 99.0%). On the other hand, <italic>rpoB </italic>gene sequence of <italic>M. farcinogenes </italic>DSM 43637 [GenBank: <ext-link ext-link-type="gen" xlink:href="AY544910">AY544910</ext-link>] was diverged from that of SMC-7485 (94.7% similarity). ITS sequence (327 bp) analysis also suggested that the strain SMC-7485 belonged to <italic>M. senegalense</italic>. The strain SMC-7485 showed an identical ITS sequence with <italic>S. senegalense </italic>MF-417 [GenBank: <ext-link ext-link-type="gen" xlink:href="AY684051">AY684051</ext-link>]. In addition, ITS sequence of SMC-7485 showed the similarities of more than 90% with those of several <italic>M. senegalense </italic>strains deposited in GenBank database. Although ITS sequences of some <italic>M. senegalense </italic>strains such as ATCC 35796 and NCTC 10956 showed low similarities (80.9%) with that of SMC-7485, they were clearly differentiated from <italic>M. farcinogenes </italic>and other <italic>Mycobacterium </italic>species (Fig. <xref ref-type="fig" rid="F1">1</xref>). Based on 16S rRNA gene, <italic>rpoB </italic>gene, and ITS sequences, we could identify SMC-7485 as <italic>M. senegalense</italic>.</p>
      <fig position="float" id="F1">
        <label>Figure 1</label>
        <caption>
          <p>Phylogenetic relationships of SMC-7485 and other <italic>Mycobacterium </italic>species based on ITS sequences, which were retrieved from GenBank database. This tree was generated by the neighbor-joining method. <italic>Mycobacterium vaccae </italic>DSM 43292 was used as an outlier. Numbers at branching nodes are percentages of 1,000 bootstrap replications. Only values greater than 50% are shown. In this tree, <italic>M. senegalense </italic>strains are separated into two subgroups.</p>
        </caption>
        <graphic xlink:href="1471-2334-5-107-1"/>
      </fig>
      <p>The nucleotide sequences of the 16S rRNA gene, <italic>rpoB</italic>, and ITS of the strain SMC-7485 have been deposited in the GenBank database under accession numbers <ext-link ext-link-type="gen" xlink:href="DQ145802">DQ145802</ext-link> to <ext-link ext-link-type="gen" xlink:href="DQ145804">DQ145804</ext-link>.</p>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>Rapidly growing mycobacteria such as the <italic>M. fortuitum </italic>group, the <italic>M. chelonae/abscessus </italic>group, and the <italic>M. smegmatis </italic>group are capable of thriving in even the most hostile environments [<xref ref-type="bibr" rid="B10">10</xref>]. Due to their ubiquitous capability, human infections by the rapidly growing mycobacteria have been identified with increasing frequency worldwide. Especially, rapidly growing mycobacteria are being recognized as one of the significant pathogens of catheter-related infections in immunocompromised hosts. Among rapidly growing mycobacteria, the <italic>M. fortuitum </italic>group is the most common mycobacterial pathogen for this clinical condition [<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B11">11</xref>].</p>
      <p>The <italic>M. fortuitum </italic>group included <italic>M. fortuitum, M. peregrinum</italic>, <italic>M. mucogenicum, M. senegalense, M. mageritense</italic>, and several newly described species such as <italic>M. septicum, M. houstonense</italic>, <italic>M. boenickei, M. neworleansense</italic>, and <italic>M. brisbanense </italic>[<xref ref-type="bibr" rid="B12">12</xref>]. Of these, <italic>M. senegalense </italic>was originally described by Chamoiseau in 1973 as a subspecies of <italic>M. farcinogenes</italic>. Although <italic>M. farcinogenes </italic>and <italic>M. senegalense </italic>have identical 16S rRNA gene sequences, <italic>M. senegalense </italic>could be identified as a different species based on differences in growth rate, chemical activity and DNA homology [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B14">14</xref>]. While most species of <italic>M. fortuitum </italic>group have been reported to be responsible for various human diseases, human infection by <italic>M. senegalense </italic>has not been described to date [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B12">12</xref>]. Instead, it causes the chronic infectious disease of zebu cattle known as bovine farcy, endemic to East and Central Africa [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B9">9</xref>]. Moreover, <italic>M. senegalense</italic>, which was originally found in Africa, has never been described elsewhere [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B10">10</xref>].</p>
      <p>In this report, we have first documented the CVC infection caused by <italic>M. senegalense</italic>. Because conventional automated methods failed to identify it at the species level, we tried to sequence 16S rRNA gene, <italic>rpoB </italic>gene, and ITS region. By 16S rRNA gene, <italic>rpoB </italic>gene, and ITS sequence analyses, we concluded that an agent of CVC infection in our patient was <italic>M. senegalense</italic>. <italic>rpoB </italic>gene and ITS sequences could differentiate <italic>M. senegalense </italic>from <italic>M. farcinogenes </italic>clearly as in previous reports [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B14">14</xref>]. Moreover, ITS sequence analysis indicated that <italic>M. senegalense </italic>might consist of at least two heterogeneous groups (Fig. <xref ref-type="fig" rid="F1">1</xref>). There is possibility that <italic>M. senegalense </italic>isolate related to human infection has been misidentified as different species because it is difficult to identify nontuberculous mycobacteria (NTM) at the species level [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B16">16</xref>]. However, the strain SMC-7485 is the first described <italic>M. senegalense </italic>isolate, which is associated with human infection and is found outside Africa, to our knowledge.</p>
      <p>In most cases with mycobacterial infection of CVC, the line should be removed for successful control of infection [<xref ref-type="bibr" rid="B17">17</xref>]. In this study, the patient failed to respond to an initial regimen of imipenem and amikacin, to which the isolate was susceptible. Persistent infection was controlled after removal of catheter, which emphasized the importance of catheter removal. Because of differences in susceptibilities among species and even within species, rapid identification and subsequent susceptibility testing are essential for selection of appropriate antibiotic agent(s) against rapidly growing mycobacteria [<xref ref-type="bibr" rid="B18">18</xref>]. In this study, the strain SMC-7485 was susceptible to amikacin, cefoxitin, ciprofloxacin, clarithromycin, doxycycline, and imipenem. Because of the high frequency of relapse and resistance, combination therapy with multiple antibiotics is usually recommended for serious infections by rapidly growing mycobacteria. However, the optimal antibiotic regimen has yet to be defined for catheter-related infection by these mycobacteria. In our experience, oral antibiotic therapy subsequent to a short course of intravenous antibiotics seemed to be effective and safe. Although it was not possible to determine the optimal duration of antibiotic therapy in our case, this episode was successfully treated with short-term (approximately 5 weeks) antibiotic therapy. Further studies will be required to confirm these findings.</p>
    </sec>
    <sec>
      <title>Conclusion</title>
      <p>In this paper, we firstly reported catheter-associated bacteremia by <italic>M. senegalense</italic>. This case suggested that <italic>M. senegalense </italic>can cause human infections. This pathogen should be included in the list of nontuberculous mycobacteria causing human infections.</p>
    </sec>
    <sec>
      <title>List of abbreviations</title>
      <p>CVC &#x2013; central venous catheter</p>
      <p>ITS &#x2013; internal transcribed spacer</p>
      <p>MIC &#x2013; minimum inhibitory concentration</p>
      <p>NCCLS &#x2013; National Committee for Clinical Laboratory Standards</p>
      <p>NTM &#x2013; nontuberculous mycobacteria</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The author(s) declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors' contributions</title>
      <p>WSO, SYR, KTK, and STH followed up the patient and obtained consent from the patient for this case report. WSO, KRP, and NYL provided clinical details. KSK performed the molecular identification and phylogenetic analysis, and KSK, MYL, and JHL executed antimicrobial susceptibility testing. WSO, KSK, and JHS drafted the manuscript. All authors read and approved the final manuscript.</p>
    </sec>
    <sec>
      <title>Pre-publication history</title>
      <p>The pre-publication history for this paper can be accessed here:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2334/5/107/prepub"/>
      </p>
    </sec>
  </body>
  <back>
    <ack>
      <sec>
        <title>Acknowledgements</title>
        <p>We thank Dr. Won-Jung Koh (Samsung Medical Center, Sungkyunkwan University School of Medicine) for his helpful comment on this study. This work was partly supported by the ARFID (Asian-Pacific Research Foundation for Infectious Diseases).</p>
      </sec>
    </ack>
    <ref-list>
      <ref id="B1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chamoiseau</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Etiology of farcy in African bovines: nomenclature of the causal organism <italic>Mycobacterium farcinogenes </italic>Chamoiseau and <italic>Mycobacterium senegalense </italic>(Chamoiseau) comb. nov</article-title>
          <source>Int J Syst Microbiol</source>
          <year>1979</year>
          <volume>29</volume>
          <fpage>407</fpage>
          <lpage>410</lpage>
        </citation>
      </ref>
      <ref id="B2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ridell</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Goodfellow</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Numerical classification of <italic>Mycobacterium farcinogenes, Mycobacterium senegalense </italic>and related taxa</article-title>
          <source>J Gen Microbiol</source>
          <year>1983</year>
          <volume>129</volume>
          <fpage>599</fpage>
          <lpage>611</lpage>
          <pub-id pub-id-type="pmid">6875513</pub-id>
        </citation>
      </ref>
      <ref id="B3">
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Pfyffer</surname>
              <given-names>GE</given-names>
            </name>
            <name>
              <surname>Brown-Elliott</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Wallace</surname>
              <given-names>RJ</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH</surname>
            </name>
          </person-group>
          <article-title><italic>Mycobacterium: </italic>general characteristics, isolation, and staining procedures</article-title>
          <source>Mannual of Clinical Microbiology</source>
          <year>2003</year>
          <edition>8</edition>
          <publisher-name>American Society for Microbiology, Washington, DC</publisher-name>
          <fpage>532</fpage>
          <lpage>59</lpage>
        </citation>
      </ref>
      <ref id="B4">
        <citation citation-type="book">
          <person-group person-group-type="author">
            <collab>NCCLS</collab>
          </person-group>
          <source>Susceptibility testing of Mycobacteria, Nocardiae, and other aerobic actinomycetes: approved standard. NCCLS document M24-A</source>
          <year>2003</year>
          <publisher-name>Wayne, Pennsylvania</publisher-name>
        </citation>
      </ref>
      <ref id="B5">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Lyu</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Bai</surname>
              <given-names>GH</given-names>
            </name>
            <name>
              <surname>Chae</surname>
              <given-names>GT</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>Cha</surname>
              <given-names>CY</given-names>
            </name>
            <name>
              <surname>Kook</surname>
              <given-names>YH</given-names>
            </name>
          </person-group>
          <article-title>Identification of mycobacterial species by comparative sequence analysis of the RNA polymerase gene (<italic>rpoB</italic>)</article-title>
          <source>J Clin Microbiol</source>
          <year>1999</year>
          <volume>37</volume>
          <fpage>1714</fpage>
          <lpage>1720</lpage>
          <pub-id pub-id-type="pmid">10325313</pub-id>
        </citation>
      </ref>
      <ref id="B6">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kirschner</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Kieknebeck</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Meissner</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Wolters</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>B&#xF6;ttger</surname>
              <given-names>EC</given-names>
            </name>
          </person-group>
          <article-title>Genetic heterogeneity within <italic>Mycobacterium fortuitim </italic>complex species: genotypic criteria for identification</article-title>
          <source>J Clin Microbiol</source>
          <year>1992</year>
          <volume>30</volume>
          <fpage>2772</fpage>
          <lpage>2775</lpage>
          <pub-id pub-id-type="pmid">1280641</pub-id>
        </citation>
      </ref>
      <ref id="B7">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roth</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fischer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hamid</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Michalke</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ludwig</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Mauch</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Differentiation of phylogenetically related slowly growing mycobacteria based on 16S-23S rRNA gene internal transcribed spacer sequences</article-title>
          <source>J Clin Microbiol</source>
          <year>1998</year>
          <volume>36</volume>
          <fpage>139</fpage>
          <lpage>147</lpage>
          <pub-id pub-id-type="pmid">9431937</pub-id>
        </citation>
      </ref>
      <ref id="B8">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ko</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>HK</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>MY</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>KH</given-names>
            </name>
            <name>
              <surname>Woo</surname>
              <given-names>SY</given-names>
            </name>
            <name>
              <surname>Yun</surname>
              <given-names>YJ</given-names>
            </name>
            <name>
              <surname>Kook</surname>
              <given-names>YH</given-names>
            </name>
          </person-group>
          <article-title>Population genetic structure of <italic>Legionella pneumophila </italic>inferred from RNA polymerase gene (<italic>rpoB</italic>) and DotA gene (<italic>dotA</italic>) sequences</article-title>
          <source>J Bacteriol</source>
          <year>2002</year>
          <volume>184</volume>
          <fpage>2123</fpage>
          <lpage>2130</lpage>
          <pub-id pub-id-type="pmid">11914343</pub-id>
          <pub-id pub-id-type="doi">10.1128/JB.184.8.2123-2130.2002</pub-id>
        </citation>
      </ref>
      <ref id="B9">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hamid</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Roth</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Landt</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Kroppenstedt</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Goodfellow</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mauch</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Differentiation between <italic>Mycobacterium farcinogenes </italic>and <italic>Mycobacterium senegalense </italic>strains based on 16S-23S ribosomal DNA internal transcribed spacer sequences</article-title>
          <source>J Clin Microbiol</source>
          <year>2002</year>
          <volume>40</volume>
          <fpage>707</fpage>
          <lpage>711</lpage>
          <pub-id pub-id-type="pmid">11826003</pub-id>
          <pub-id pub-id-type="doi">10.1128/JCM.40.2.707-711.2002</pub-id>
        </citation>
      </ref>
      <ref id="B10">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brown-Elliott</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Wallace</surname>
              <given-names>RJ</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <article-title>Clinical and taxonomic status of pathogenic nonpigmented or late-pigmented rapidly growing mycobacteria</article-title>
          <source>Clin Microbiol Rev</source>
          <year>2002</year>
          <volume>15</volume>
          <fpage>716</fpage>
          <lpage>746</lpage>
          <pub-id pub-id-type="pmid">12364376</pub-id>
          <pub-id pub-id-type="doi">10.1128/CMR.15.4.716-746.2002</pub-id>
        </citation>
      </ref>
      <ref id="B11">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Levendoglu-Tugal</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Munoz</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Brudnicki</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ozkaynak</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Sandoval</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Jayabose</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Infections due to nontuberculous mycobacteria in children with leukaemia</article-title>
          <source>Clin Infect Dis</source>
          <year>1998</year>
          <volume>27</volume>
          <fpage>1227</fpage>
          <lpage>1230</lpage>
          <pub-id pub-id-type="pmid">9827274</pub-id>
        </citation>
      </ref>
      <ref id="B12">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schinsky</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Morey</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Steigerwalt</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Douglas</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Floyd</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Butler</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Daneshvar</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Brown-Elliott</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Wallace</surname>
              <given-names>RJ</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>NcNeil</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Brenner</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of <italic>Mycobacterium boenickei </italic>sp. nov., <italic>Mycobacterium houstonense </italic>sp. nov., <italic>Mycobacterium neworleansense </italic>sp. nov., and <italic>Mycobacterium brisbanense </italic>sp. nov. and recognition of <italic>Mycobacterium procinum </italic>from human clinical isolates</article-title>
          <source>Int J Syst Evol Microbiol</source>
          <year>2004</year>
          <volume>54</volume>
          <fpage>1653</fpage>
          <lpage>1667</lpage>
          <pub-id pub-id-type="pmid">15388725</pub-id>
          <pub-id pub-id-type="doi">10.1099/ijs.0.02743-0</pub-id>
        </citation>
      </ref>
      <ref id="B13">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ridell</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Goodfellow</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Minnikin</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Minnikin</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Hutchinson</surname>
              <given-names>IG</given-names>
            </name>
          </person-group>
          <article-title>Classification of <italic>Mycobacterium farcinogenes </italic>and <italic>Mycobacterium senegalense </italic>by immunodiffusion and thin-layer chromatography of long-chain components</article-title>
          <source>J Gen Microbiol</source>
          <year>1982</year>
          <volume>128</volume>
          <fpage>1299</fpage>
          <lpage>1307</lpage>
          <pub-id pub-id-type="pmid">6811691</pub-id>
        </citation>
      </ref>
      <ref id="B14">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Devulder</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>de Montclos</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Flandrois</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
          <article-title>A multigene approach to phylogenetic analysis using the genus <italic>Mycobacterium </italic>as a model</article-title>
          <source>Int J Syst Evol Microbiol</source>
          <year>2005</year>
          <volume>55</volume>
          <fpage>293</fpage>
          <lpage>302</lpage>
          <pub-id pub-id-type="pmid">15653890</pub-id>
          <pub-id pub-id-type="doi">10.1099/ijs.0.63222-0</pub-id>
        </citation>
      </ref>
      <ref id="B15">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schinsky</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>McNeil</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Whitney</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Steigerwalt</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Lasker</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Floyd</surname>
              <given-names>MM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title><italic>Mycobacterium septicum </italic>sp. nov., a new rapidly growing species associated with catheter-related bacteremia</article-title>
          <source>Int J Syst Evol Microbiol</source>
          <year>2000</year>
          <volume>50</volume>
          <fpage>575</fpage>
          <lpage>581</lpage>
          <pub-id pub-id-type="pmid">10758863</pub-id>
        </citation>
      </ref>
      <ref id="B16">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Short</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Emery</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bhandary</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>O'Donnell</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Misidentification of <italic>Mycobacterium peregrinum</italic>, the causal organism of a case of bacteremia and automatic implantable cardioverter defibrillator-associated infection, due to its unusual acid-fast staining characteristics</article-title>
          <source>J Clin Microbiol</source>
          <year>2005</year>
          <volume>43</volume>
          <fpage>2015</fpage>
          <lpage>2017</lpage>
          <pub-id pub-id-type="pmid">15815048</pub-id>
          <pub-id pub-id-type="doi">10.1128/JCM.43.4.2015-2017.2005</pub-id>
        </citation>
      </ref>
      <ref id="B17">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mermel</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Farr</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Sherertz</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Raad</surname>
              <given-names>II</given-names>
            </name>
            <name>
              <surname>O'Grady</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Craven</surname>
              <given-names>DE</given-names>
            </name>
          </person-group>
          <article-title>Guidelines for the management of intravascular catheter-related infections</article-title>
          <source>Clin Infect Dis</source>
          <year>2001</year>
          <volume>32</volume>
          <fpage>1249</fpage>
          <lpage>1272</lpage>
          <pub-id pub-id-type="pmid">11303260</pub-id>
          <pub-id pub-id-type="doi">10.1086/320001</pub-id>
        </citation>
      </ref>
      <ref id="B18">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <collab>American Thoracic Society</collab>
          </person-group>
          <article-title>Diagnosis and treatment of disease caused by nontuberculous mycobacteria</article-title>
          <source>Am J Respir Crit Care Med</source>
          <year>1997</year>
          <volume>156</volume>
          <fpage>S1</fpage>
          <lpage>S25</lpage>
          <pub-id pub-id-type="pmid">9279284</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
